Technology, especially AI, is increasingly vital to the US economy, boosting capital expenditure and supporting economic performance despite challenges. However, rising interest rates pose risks that could impact market sentiment, stock valuations, and company fundamentals. This environment calls for careful selection of AI stocks, as not all are equally affected by these macroeconomic pressures. Investors should focus on discerning opportunities within the AI sector to navigate these risks effectively.
The story on macro risks for AI stocks is presented with context from the Technology sector on Pluang. For readers following Technology stocks, here is Pluang's market snapshot as of Sep 24, 2026 16:51 WIB: Of 150 priced Technology-sector US stocks, 16 rose and 127 fell today. Notable movers include AXTI at USD 69.66 with a 1-day change of -4.55% and a typical hold time of 16 days, CRDO at USD 186.00 down 4.06% with a typical hold time of 21 days, and YOU at USD 40.43 up 3.93% with a typical hold time of 17 days and 100% buy order activity.
Bank of America has been upgraded to a buy rating as its stock trades nearly 20% below fair value following a sharp selloff in Q3. The bank reported strong Q2 results with $1.21 GAAP EPS and $31.6 billion in revenue, driven by net interest income and...
Scottie Resources Corp. announced a private placement offering to raise up to C$10 million by selling 3,448,275 shares at C$2.90 each, with an option to raise an additional C$2 million. Alongside an amended non-brokered private placement of C$17 mill...
Bitcoin's market cap dropped by $49.1 billion in 24 hours, but analyst Ali Martinez expects a rally toward $100,000, citing strong support at $82,500. Bitcoin currently trades around $83,120, with a potential 20% upside after a possible consolidation...
Bitcoin's market cap dropped by $49.1 billion recently, but analyst Ali Martinez expects a rally to $100,000, citing a strong support level at $82,500. The price currently hovers around $83,120, with potential upside of over 20%. This optimism is sup...
Viking Therapeutics announced the pricing of its public offerings, raising up to $275 million through common stock and convertible senior notes. The company plans to use the proceeds to advance clinical development and commercialization of its obesit...
